Modern Testing Paradigms to Enhance Human Risk Assessment and New Strategies Aimed at Reducing Animal Use
Join us for a Charles River Presents half-day symposium at:
Farmer and The Seahorse
10996 Torreyana Rd
San Diego, CA
Alan M. Hoberman, PhD, DABT, Fellow ATS
Executive Director, Global Developmental, Reproductive, and Juvenile Toxicology
Elise M. Lewis, PhD
Senior Director of Toxicology
Kristina York, MSc
Research Scientist II
Though the basic principles for identifying hazard and characterizing reproductive risk for human pharmaceuticals have not changed over the past 50 years, the concepts regarding the ability of agents to affect reproductive and development outcomes continue to evolve. Since the adoption of the ICH S5(R2) Guideline in the early 1990s, continued advances in science, technology, and regulatory knowledge, and application of the 3Rs principles, mean the drug development industry is now on the forefront of modern approaches to testing of medicinal products.
Join your colleagues for a morning of stimulating presentations, as Charles River scientists introduce modern testing paradigms and new strategies to potentially reduce animal use. Our agenda includes plenty of time for networking and discussion.
Update on the ICH S5 Testing Guidance for Reproductive and Developmental Safety Assessment
|10:15||Current Practical Uses of Microsampling|
What You Need to Know About NHP DART